
AUC3 is a dynamic and interactive, two-day live meeting where selected panel members representing multiple disciplines will debate and vote on diagnostic and management strategies for kidney and bladder cancer. Panel members are chosen before the live meeting, and consensus questions are developed through an iterative process involving conference directors and panel members.
At the AUC3 live meeting, panel members with expertise in the specific consensus question present available data. Panel members debate and vote on each consensus question. After the live meeting, conference directors, together with panel members, will develop and draft the consensus guidelines manuscript for publication and endorsement through national and international channels organizations.
Tremendous progress has been made in the treatment of patients with advanced urologic cancers, but experts believe critical questions remain that are unable to be answered by robust prospective clinical trials. AUC3 aims to address this scarcity of information.
For additional information or inquiries, please provide your contact information and we will be in touch shortly.
Additionally, we would love to hear from you!
If preferred, reach out to Consensus@auc3.com directly.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.